Partnership to improve cancer care launches in Sudan
The government of Sudan and Roche launched a comprehensive program to fight against cancer in August 2017. It builds a corner stone to fight breast and blood cancers by providing patients with access to innovative biotech medicines as well as state of the art diagnostic solutions.
The public-private partnership’s planned activities include improvements in screening and diagnostics, including the placement of a state-of-the-art diagnostic system capable of advanced testing for seven types of cancer. Additionally, the collaboration will support training activities for physicians, pathologists, pharmacists and nurses. The joint efforts of the Government of Sudan and Roche also cover the cost medicines and related diagnostics in public cancer treatment centers across the country, resulting in no costs to patients themselves. The aim of these measures is to improve access to timely and precise diagnostic services and tailored cancer treatment to make cancer therapy much more effective. The partnership will also strengthen the collection of data and scientific analysis of it to further strengthen information about cancer in Sudan.
Cancer is one of the leading non-communicable diseases in Sudan. Early diagnosis and treatment with innovative pharmaceuticals could greatly reduce the burden of the disease and improve treatment outcomes.
This program marks a new milestone how governments fight cancer in Sub-Saharan Africa and is one of the best even across the continent. The Federal Minister of Health of Sudan, Bahr Idris Abu Garda, expressed during the launch his vote of thanks to Roche for being a partner in this complex program. During the inauguration ceremony Wife of the President of the Republic of Sudan, Widad Babikir, said: “This is a big achievement for our cancer patients that they get free access to modern treatment and diagnostic solutions.”
Roche Africa Strategy
The agreement is part of our Africa Strategy which began in 2015 in eight countries: Sudan, Nigeria, Ghana, Kenya, Côte d’Ivoire, Angola, Ethiopia and Gabon. Based on country needs and capabilities, we are implementing a wide selection of activities in collaboration with local partners, including healthcare system strengthening, such as local data generation and advocacy for healthcare prioritization; disease management support, such as awareness, advocacy campaigns and treatment guidelines; and education and market access solutions, including healthcare professional training, private health insurance with local companies and agreements with governments.